Skip to main content

Peer Review reports

From: Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial

Original Submission
16 Jul 2015 Submitted Original manuscript
1 Sep 2015 Author responded Author comments - Tetsuya Fujimura
31 Jul 2015 Reviewed Reviewer Report - Zhanwei Wang
28 Jul 2015 Reviewed Reviewer Report - Christian Ostheimer
Resubmission - Version 2
1 Sep 2015 Submitted Manuscript version 2
16 Oct 2015 Author responded Author comments - Tetsuya Fujimura
16 Sep 2015 Reviewed Reviewer Report - Zhanwei Wang
Resubmission - Version 3
16 Oct 2015 Submitted Manuscript version 3
Publishing
26 Oct 2015 Editorially accepted
2 Nov 2015 Article published 10.1186/s12885-015-1871-z

You can find further information about peer review here.

Back to article page